We are proud to announce that the United States Patent and Trademark Office (USPTO) has officially allowed BrainScan’s patent application titled “Pathological anomaly detection in DICOM images and generation of a summary image.”
This patent protects BrainScan’s proprietary technology for automatic detection of pathological anomalies in CT brain scans and the generation of a standardized summary image embedded directly in DICOM files.
Our patented innovation enables:
- Automated identification of multiple types of brain pathologies in a single CT study using advanced machine learning models trained on clinical datasets.
- Precise graphical marking of detected anomalies within CT slices.
- Creation of a summary graphic image that includes:
- an overview of abnormalities detected,
- visual examples of pathological findings with localization,
- a structured textual list of findings with detection scores,
- and information about pathologies evaluated but not detected above threshold.
- Seamless integration of the summary image into DICOM, ensuring radiologists and clinicians receive an enriched study without disrupting existing workflows.
This milestone further strengthens BrainScan’s intellectual property portfolio and confirms our position among the global leaders in AI-driven medical imaging. It is also a testament to the originality of our approach, as USPTO examiners determined that none of the prior art anticipated or suggested our system’s capabilities.
The allowed claims cover a broad scope of AI functionality within diagnostic imaging, giving BrainScan strong protection in one of the most important markets worldwide – the United States.
With this achievement, we continue our mission to bring the most advanced AI tools to radiologists and healthcare providers, supporting faster, more accurate, and standardized brain CT interpretation.
